Walvax Biotechnology Co., Ltd., a biological pharmaceutical company, researches and develops, produces, and sells bio-medicine products in China. The company offers biomedicines, such as vaccines, blood products, and others. It provides Group A, C meningococcal polysaccharide conjugate vaccine for infants below or equal to 2 years preventing diseases, such as cerebrospinal meningitis and septicemia; Group A and C meningococcal polysaccharide vaccine for in adults and children over the age of 2 years and adults to prevent disease caused by the bacterium Neisseria meningitidis group A or group C; and Group ACYW135 meningococcal polysaccharide vaccine for children above 2 years old to prevent epidemic cerebrospinal meningitis caused by Neisseria meningitidis group A, C, Y, and W135. The company also offers haemophilus influenzae type b conjugate vaccine for children from the age of 2 months to 5 years for the prevention of infectious diseases, including meningitis, pneumonia, septicemia, cellulitis, arthritis, epiglottitis, etc. In addition, it provides diphtheria, tetanus, and acellular pertussis combined vaccine for the prevention of diphtheria, tetanus, and pertussis for individuals from the age of 3 months to 6 years; and 23-valent pneumococcal polysaccharide vaccine for children above 2 years old to prevent pneumococcal disease caused by 23 serotypes. Walvax Biotechnology Co., Ltd. was founded in 2001 and is headquartered in Kunming, China.
Walvax Biotechnology Dividend Announcement
• Walvax Biotechnology announced a annually dividend of ¥0.01 per ordinary share which will be made payable on 2024-05-30. Ex dividend date: 2024-05-30
• Walvax Biotechnology annual dividend for 2024 was ¥0.01
• Walvax Biotechnology annual dividend for 2023 was ¥0.01
• Walvax Biotechnology's trailing twelve-month (TTM) dividend yield is 0.07%
• Walvax Biotechnology's payout ratio for the trailing twelve months (TTM) is 35.40%
Walvax Biotechnology Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-05-30 | ¥0.01 | annually | 2024-05-30 |
2023-05-11 | ¥0.01 | annually | 2023-05-11 |
2022-04-26 | ¥0.03 | annually | 2022-04-26 |
2021-05-19 | ¥0.05 | annually | 2021-05-19 |
2020-09-30 | ¥0.02 | annually | 2020-09-30 |
2019-07-23 | ¥0.03 | annually | 2019-07-23 |
2015-04-23 | ¥0.05 | annually | |
2014-05-30 | ¥0.07 | annually | |
2013-06-19 | ¥0.25 | annually | |
2012-05-07 | ¥0.30 | annually | |
2011-09-16 | ¥0.30 | annually |
Walvax Biotechnology Dividend per year
Walvax Biotechnology Dividend growth
Walvax Biotechnology Dividend Yield
Walvax Biotechnology current trailing twelve-month (TTM) dividend yield is 0.07%. Interested in purchasing Walvax Biotechnology stock? Use our calculator to estimate your expected dividend yield:
Walvax Biotechnology Financial Ratios
Walvax Biotechnology Dividend FAQ
Other factors to consider when evaluating Walvax Biotechnology as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Walvax Biotechnology stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Walvax Biotechnology's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Walvax Biotechnology publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Walvax Biotechnology distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Walvax Biotechnology are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Walvax Biotechnology sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Walvax Biotechnology distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Walvax Biotechnology declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Walvax Biotechnology's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Walvax Biotechnology's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.